CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-01 | MODUR VIJAY HEAD OF R&D | Grant or award · Restricted Stock Units | +44,683 | 219,326 | ||
| 2021-04-01 | MODUR VIJAY HEAD OF R&D | Grant or award · Stock Options (Right to Buy) | +711,619 | 711,619 | ||
| 2021-04-01 | Aggarwal Sumit PRESIDENT AND CEO | Grant or award · Restricted Stock Units | +223,304 | 223,304 | ||
| 2021-04-01 | Aggarwal Sumit PRESIDENT AND CEO | Grant or award · Restricted Stock Units | +55,854 | 279,158 | ||
| 2021-04-01 | Aggarwal Sumit PRESIDENT AND CEO | Grant or award · Stock Options (Right to Buy) | +1,423,238 | 1,423,238 | ||
| 2021-02-25 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option exercise | +25,000 | 33,415 | ||
| 2021-02-25 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Shares withheld for taxes | −7,338 | $3.95 | $29K | 26,077 |
| 2021-02-25 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option exercise · Restricted Stock Units | −25,000 | 75,000 | ||
| 2021-02-25 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Option exercise | +50,000 | 59,989 | ||
| 2021-02-25 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −15,360 | $3.95 | $61K | 44,629 |
| 2021-02-25 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −50,000 | 150,000 | ||
| 2021-02-12 | MacDonald Stephen G. VP FINANCE & ACCTG, TREASURER | Grant or award · Stock Options | +18,849 | 18,849 | ||
| 2021-02-12 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Grant or award · Stock Options | +120,000 | 120,000 | ||
| 2021-02-12 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Grant or award · Stock Options | +300,000 | 300,000 | ||
| 2021-01-30 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Option exercise | +1,875 | 10,632 | ||
| 2021-01-30 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −643 | $3.44 | $2K | 9,989 |
| 2021-01-30 | Williams Gregory C. CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −1,875 | 15,000 | ||
| 2021-01-30 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option exercise | +1,563 | 8,957 | ||
| 2021-01-30 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Shares withheld for taxes | −542 | $3.44 | $2K | 8,415 |
| 2021-01-30 | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | Option exercise · Restricted Stock Units | −1,563 | 12,500 |
Page 7 of 11 · 206 trades